C L Flemming - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

C L Flemming

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Human Gene Therapy|May 1, 1994

Generation of interleukin-2-secreting melanoma cell populations from resected metastatic tumorsP M Patel, C L Flemming, C Fisher, et al.

Clinical and Experimental Immunology|August 1, 1996

IL-12 stimulation but not B7 expression increases melanoma killing by patient cytotoxic T lymphocytes (CTL)D De Wit, C L Flemming, J D Harris, et al.

British Journal of Cancer|August 1, 1993

Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumourP M Patel, C L Flemming, S J Russell, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Human Gene Therapy|May 1, 1994

Generation of interleukin-2-secreting melanoma cell populations from resected metastatic tumorsP M Patel, C L Flemming, C Fisher, et al.

Clinical and Experimental Immunology|August 1, 1996

IL-12 stimulation but not B7 expression increases melanoma killing by patient cytotoxic T lymphocytes (CTL)D De Wit, C L Flemming, J D Harris, et al.

British Journal of Cancer|August 1, 1993

Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumourP M Patel, C L Flemming, S J Russell, et al.

Pageof 2